Literature DB >> 8667569

Performance-enhancing drugs, fair competition, and Olympic sport.

D H Catlin1, T H Murray.   

Abstract

Drug control has become an important component of Olympic sport. At the Atlanta Centennial Olympic Games, urine samples will be tested for prohibited substances, including stimulants, narcotics, anabolic agents, diuretics, peptides, and glycoprotein hormones as well as prohibited methods of enhancing performance, including blood doping and pharmacological, chemical, and physical manipulation of the urine. Drug testing programs must address short-acting stimulants, beta-blockers, and diuretics; training drugs such as anabolic steroids; and drugs affecting the detectability of other drugs. Programs include short- or no-notice testing during training periods, testing at qualifying competitions, and testing at the Olympic Games. Procedures and disposition that occur when a prohibited substance is found in an athlete competing in an Olympic sport are discussed. An analysis of the ethics of the use of performance-enhancing drugs in sports and of drug control in terms of fair competition and the impact of enhancement technologies of the meaning of sports also is presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667569

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  14 in total

Review 1.  A conceptual framework for achieving performance enhancing drug compliance in sport.

Authors:  Robert J Donovan; Garry Egger; Vicki Kapernick; John Mendoza
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Why we should allow performance enhancing drugs in sport.

Authors:  J Savulescu; B Foddy; M Clayton
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

Review 3.  Hormones as doping in sports.

Authors:  Leonidas H Duntas; Vera Popovic
Journal:  Endocrine       Date:  2012-09-19       Impact factor: 3.633

Review 4.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

5.  Performance Enhancement by Brain Stimulation.

Authors:  Parisa Gazerani
Journal:  J Sports Sci Med       Date:  2017-08-08       Impact factor: 2.988

Review 6.  Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.

Authors:  Randall L Wilber
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

7.  Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.

Authors:  Gen Kanayama; James I Hudson; James DeLuca; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Shalender Bhasin; Harrison G Pope
Journal:  Addiction       Date:  2015-02-25       Impact factor: 6.526

Review 8.  Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating?

Authors:  D R Mottram
Journal:  Sports Med       Date:  1999-01       Impact factor: 11.136

Review 9.  Anabolic-androgenic steroid dependence? Insights from animals and humans.

Authors:  Ruth I Wood
Journal:  Front Neuroendocrinol       Date:  2008-01-03       Impact factor: 8.606

10.  Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.

Authors:  Gen Kanayama; James DeLuca; William P Meehan; James I Hudson; Stephanie Isaacs; Aaron Baggish; Rory Weiner; Lyle Micheli; Harrison G Pope
Journal:  Am J Sports Med       Date:  2015-09-11       Impact factor: 6.202

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.